Clinical Trials · NCT05193578
Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Jan Frystyk
- Enrollment
- 154
- Start date
- Jan 2022
- Locations
- 1 site, Denmark
- Primary endpoint
- HbA1c (mmol/mol)